Search by Drug Name or NDC

    NDC 00003-2818-11 ORENCIA 87.5 mg/.7mL Details

    ORENCIA 87.5 mg/.7mL

    ORENCIA is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is ABATACEPT.

    Product Information

    NDC 00003-2818
    Product ID 0003-2818_ca83b90c-3ec0-4803-bf69-18c035bc41f0
    Associated GPIs 6640001000E515
    GCN Sequence Number 077400
    GCN Sequence Number Description abatacept SYRINGE 87.5MG/0.7 SUBCUT
    HIC3 S2Q
    HIC3 Description ANTINFLAMMATORY, SEL.COSTIM.MOD.,T-CELL INHIBITOR
    GCN 43397
    HICL Sequence Number 037825
    HICL Sequence Number Description ABATACEPT
    Brand/Generic Brand
    Proprietary Name ORENCIA
    Proprietary Name Suffix n/a
    Non-Proprietary Name abatacept
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 87.5
    Active Ingredient Units mg/.7mL
    Substance Name ABATACEPT
    Labeler Name E.R. Squibb & Sons, L.L.C.
    Pharmaceutical Class Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125118
    Listing Certified Through 2024-12-31

    Package

    NDC 00003-2818-11 (00003281811)

    NDC Package Code 0003-2818-11
    Billing NDC 00003281811
    Package 4 SYRINGE, GLASS in 1 CARTON (0003-2818-11) / .7 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2017-03-30
    NDC Exclude Flag N
    Pricing Information N/A